Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Treatment for Pilon Fractures with N-Acetylcysteine Injection

Official title: Prevention of Cartilage Cell Death Following a Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)

Run by University of Missouri-Columbia · NCT03652753 · Data updated 2026-11-12

This study is testing if an injection of N-acetylcysteine can help people with high energy pilon fractures avoid developing arthritis after their injury.

More Pilon Fracture trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedJanuary 1, 2019
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedApril 28, 2026
Trial IDNCT03652753 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with closed high energy pilon fractures requiring a staged surgical procedure.

Probably not a fit

Patients with open fractures, intra-articular injuries not requiring a staged procedure, or those with allergies to NAC may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the use of N-acetylcysteine (NAC) as an intra-articular injection for patients with high energy pilon fractures. The study aims to assess whether NAC can reduce the incidence of post-traumatic osteoarthritis (PTOA), a common complication following these injuries. Participants will receive either NAC or saline as a control during a staged surgical procedure. The trial is designed to evaluate the effectiveness of NAC in improving long-term outcomes for patients suffering from this type of fracture.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce the risk of developing post-traumatic osteoarthritis in patients with pilon fractures.

How similar studies have gone: While the use of NAC in this context is novel, other studies have explored its benefits in different orthopedic applications, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Closed high energy pilon fracture requiring a staged procedure

Exclusion Criteria:

* Younger than 18
* Open fracture
* Intra-articular injury not requiring a staged procedure
* Allergy to NAC
* Wounds preventing safe intra-articular injection
* Unwilling to participate in the study
* Pregnancy

Where it's running

  • University of Missouri Health System
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.